Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Jonthan Brown

  • Home
  • Author: Jonthan Brown

BARDA supports Moderna’s COVID-19 vaccine candidate but many obstacles ahead to confirm potential of mRNA vaccine strategy

The Biomedical Advanced Research and Development Authority (BARDA) has agreed to provide up to $483m to assist Moderna in developing its COVID-19 vaccine candidate, but reporting from Reynald Castañeda, Pharma Writer for the Investigative News team at GlobalData, a leading data and analytics company, shows that experts are cautious about mRNA-1273’s potential to trigger sufficient immunogenicity. Castañeda says: “From […]
Read more

Exports of N95 and KN95 from China to ease burden on US manufacturers

Due to the huge shortage of PPE among first responders, healthcare workers and medical staff in the US, it is unlikely that import of KN95 will negatively impact sales of US-made N95 respirators, says GlobalData, a leading data and analytics company. Alison Casey, Medical Devices Analyst at GlobalData, comments: “There is currently an unprecedented shortage of personal protective equipment (PPE) such as N95 respirators in the US and companies such as 3M Co, Honeywell International, Owens & Minor and Prestige […]
Read more

France cash transactions set to decline to 2023 and consumer spending deteriorates

France’s payments industry will be hit by ongoing disruption to its essential tourism industry, though e-commerce is seeing increases, says GlobalData. GlobalData’s post-COVID-19 revised-forecasts predict cash transactions will change from steady growth to yearly declines between 201 and 2023. Cash transactions are now set to fall at a compound annual growth rate (CAGR) of -2.3% up to 2023. Ravi Sharma, Banking and Payments Analyst at GlobalData, commented: “The French tourism industry is particularly reliant on Chinese consumers, as […]
Read more

OPEC+ cuts and COVID-19 crisis reduce revenues from Russia’s newest greenfield developments by US$20bn over three years

Following news that OPEC+ has agreed to cut production by 9.7 million per day, with Russia and Saudi Arabia assuming the biggest production reductions; Anna Belova, Senior Oil & Gas Analyst at GlobalData, a leading data and analytics company, offers her view on the current events: “As soon as the cut details were finalized, questions arose as to how Russia would be able to fulfil its […]
Read more

3M and Cummins just one of the cross-industry partnerships needed to address equipment shortages

Following the announcement of technology giant 3M Co and engine manufacturer Cummins to join forces in the fight against COVID-19; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “3M Co has ramped up its production of N95 respirators, doubling its normal output. The company is currently manufacturing 100 million N95 respirators per month worldwide, with 35 million of these being produced in the US. Partnering with Cummins is expected to enable a further increase in respirator […]
Read more

Likely postponing of Rafale deliveries exposes the vulnerability of smaller production lines to COVID-19 disruption

Following the news that Dassault will likely have to postpone the delivery of four Rafale fighter jets to India; Nicolas Jouan, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view on Dassault’s situation; “The lockdown imposed by the French Government, recently extended until mid-May at least, has imposed an interruption of work on Dassault’s assembly line in Bordeaux-Mérignac. In normal times, Dassault’s factory can build 3 Rafale aircrafts per month at […]
Read more

Taking on more debt a necessary evil for US airlines

Following the announcement that major US airlines have reached a deal in principle with the federal government to secure aid; Nick Wyatt, Head of R&A and Travel & Tourism at GlobalData, a leading data and analytics company, offers his view on the situation: “US airlines will need to take on additional debt as some of the government aid comes in the form of interest-bearing loans. While this is not the outcome they had hoped for, it is a necessary evil that may just secure […]
Read more

Nanoparticles may be used to make safer and more effective RNA-based therapeutics

A number of pharmaceutical companies have RNA-based therapeutics and vaccines in development for COVID-19. However, there are a number of safety concerns around the use of viral vectors with these therapies and the use of lipid-based nanoparticles may offer a safer alternative, says GlobalData, a leading data and analytics company. Kathryn Whitney, MSc, Director of Thematic Analysis, comments: “RNA has received considerable research attention in recent years and has the […]
Read more

Air Arabia and Etihad risking the success of joint venture low-cost airline

Following the announcement that Air Arabia and Etihad will not delay the launch of the joint venture low-cost carrier in Q2 2020; Amber Barnes, Travel and Tourism Analyst at GlobalData, a leading data and analytics company, offers her view: “Not delaying the launch could be setting the low-cost airline up for failure from the onset. In the short term the airline may prove to be an economic challenge due to current low demand that is seeing many airlines grounding fleets and seeking government help. “The future is extremely uncertain as the lengths of all travel restrictions […]
Read more

Nanotechnology being used by researchers in fight against COVID-19

With the accelerating global burden from the COVID-19 pandemic, researchers are rapidly searching for a viable vaccine or therapeutic to combat the global public health emergency. One of the approaches being investigated is the use of nanotechnology, says GlobalData, a leading data and analytics company. An international collaboration has developed a nanotechnology approach to halting […]
Read more

Novartis’ Isturisa provides new hope to Cushing’s disease market

Novartis’ Isturisa (osilodrostat) leads recent innovation in Cushing’s disease (CD) with its latest Food and Drug Administration (FDA) approval, says GlobalData, a leading data and analytics company. Isturisa, an 11-beta-hydroxylase inhibitor, is the first FDA approved drug to directly target overproduction of cortisol, the hormone of issue in CD. The drug has proven to be […]
Read more

COVID-19 presents an opportunity for beauty retailers as salons remain closed

Sales opportunities for non-food retailers are scarce amid the COVID-19 pandemic as lockdowns are enforced and non-essential stores remain temporarily closed. However, with 59.8% of consumers globally using salons and spas for treatments*, the desire to replicate salon treatments at home will provide a much needed revenue stream for beauty retailers, says GlobalData, a leading […]
Read more

Fragile supply chains will complicate car factory re-starts

As some car manufacturers contemplate strategies for manufacturing plant re-starts over the next four weeks; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his views: “This will not be an easy process of simply opening the factory gates and quickly getting back to normal. For one thing, the public health […]
Read more

Eagle Ford natural gas production benefiting from crude oil price crash

The oil price crash has forced Eagle Ford operators to re-evaluate their cash flows, cutting capital expenditure and rig count in 2020. By assessing the readjustment of capital expenditure (capex) of 16 companies, which account for approximately 75% of total Eagle Ford production, GlobalData, a leading data and analytics company, estimates a reduction of approximately […]
Read more
1 … 32 33 34 35 36 37